The herpes simplex keratitis treatment market is expanding due to rising HSV infections, increased healthcare spending, ...

Simplex Holdings (TSE:4373) delivered standout results with EPS surging 62.7% over the past year, well above its five-year average of 22.6% per year. The company’s net profit margin rose to 18.7%, up ...

Journalist who covered cartels murdered; message left next to body Watch baby burst into giggles as boxer dog gets the zoomies 10 Divorced Men On The Moment They Knew Their Marriage Was Over ...

Following Blue Origin’s New Glenn rocket firing its seven BE-4 engines on the first stage for 38 seconds, the path has been ...

WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

Blue Origin's heavy lift New Glenn became the first commercial rocket to make it to orbit on its first try back in January.

The K8.05 trillion National 2025/26 Budget faces a reality check as Minister of Finance, Economic Planning and ...

Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis: Paris Monday, November 10, ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

The first dual-satellite mission to another planet, NASA's ESCAPADE (Escape and Plasma Acceleration and Dynamics Explorers), is scheduled for launch no earlier than Sunday, Nov. 9, from Cape Canaveral ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...

Following a successful first flight in January, Blue Origin is set to launch its heavy-lift New Glenn rocket from Florida ...